- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03925623
Design Factors for Evaluating Child Resistant Packaging
Each year over 59,000 children under the age of 5 are taken to emergency rooms (equivalent to 4 busloads of children arriving every day to the ER) because they were able to get into medication containers unsupervised. 95 percent of these ER visits occurred due to the child getting into medicine when an adult was not looking.
Child resistant containers (CRC) are intended to restrict entry by imposing a cognitive barrier (the child must understand how to operate the CRC mechanism in order to open it) and a physical barrier (the child must posses the motor skills necessary to operate the CRC).
We are testing a design which changes the physical area available for grip utilizing anthropometric data that, in theory, would exclude children and enable adults.
We will evaluate the proposed design's effectiveness in two ways (1: cognitive barrier) will the child understand where they need to specifically grip the cap with their fingers and (2: physical barrier) will the child be able to use an appropriate gripping strategy to apply enough torque to rotate the cap and open it.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In order to evaluate the effectiveness of cognitive and physical barriers as child resistant design features, we are testing designs which change the physical area available for grip utilizing anthropometric data that, in theory, would exclude children and enable adults. Testing will be conducted with children aged between 42-54 months of age. Our testing is adapted from testing dictated by 16 CFR 1700; this testing is mandated by the Poison Prevention Packaging Act of 1970 and is used throughout the United States (and, in fact, adapted by much of the world) to verify the performance of child resistant packaging. The maximum age limit specified by 16 CFR 1700 is 51 months so the child testing for this study represents a more severe test of the closure.
One type of package is being tested: a 38mm diameter neck 400 thread finish (38/400) bottle that is typical of what is used to hold over-the-counter (OTC) medications. The bottle is outfitted with a two-piece continuous thread screw cap closure. Three treatments of the screw cap are being evaluated. One treatment attempts to restrict children from accessing the package using a cognitive paradigm (design intuitiveness for opening) the second treatment leverages a physical paradigm (anthropometric characteristics of the hand to keep them out) and the third treatment, the control, is a standard OTC push-down and turn child resistant screw cap.
Summary
Children will be recruited with the help of the Michigan State University Child Development Labs (MSU CDL) and testing will take place in a designated room within the Wilkshire Early Childhood Center in Haslett, Michigan and/or Early Learning Institute (ELI) preschool in East Lansing, MI. Approximately 120 children will test a single treatment of the three (N=40 per treatment); attempts will be made to counterbalance age and sex by treatment . The width of each child's thumbs will be measured by taking a digital photographic with their hand place on a grid of known dimensions. Testing will then occur in two 5 minute segments for each treatment (as with the regulated protocol overseen by CPSC).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Michigan
-
East Lansing, Michigan, United States, 48823
- Michigan State University Child Development Laboratory- East Lansing
-
East Lansing, Michigan, United States, 48824
- School of Packaging
-
Haslett, Michigan, United States, 48840
- Wilkshire Early Childhood Center-
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Be aged between 42 months to 54 months at the time of testing Have IRB approved consent form signed by parent or guardian Haver permission to be video taped Provide verbal assent (or assent through body language- head nod, etc)
Exclusion Criteria:
- No history of food allergies of any kind
- No known issues with lactose, including lactose intolerance or allergy
- Have no physical or mental impairments that impact their ability to open packages
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Commercial closure system
Participants (42-54 months of age) will be assigned to try to open one of three treatments.
One cohort will receive a 38/400 bottle equipped with a standard two piece push and turn cap and asked to open this during 2 five minute trials.
|
Two novel designs for child resistant closures are tested. One is sized based on the anthropometric properties of adults and children's hands such that it should disallow children from engaging the system and enable adults (the physically based design strategy). The other replicates the first design, but is sized such that either of the two populations should be able to engage the closure. In testing this way, we begin to differentiate the paradigm that holds the children out (the cognitively based design strategy-- they do not understand and/or a physical one- they are unable to use the closure). Results (proportion of children opening within the first or second five minute periods of test and time to opening during the same) from each of these, will be compared to results from the third treatment, a standard, commercially available push and turn system. |
Physically based design strategy
Participants (42-54 months of age) will be assigned to try to open one of three treatments.
One cohort will receive a 38/400 bottle equipped a novel closure that was designed using anthropometric data such that it disallows children from engaging the system and enables adults.
Children will be asked to open this during 2 five minute trials.
|
Two novel designs for child resistant closures are tested. One is sized based on the anthropometric properties of adults and children's hands such that it should disallow children from engaging the system and enable adults (the physically based design strategy). The other replicates the first design, but is sized such that either of the two populations should be able to engage the closure. In testing this way, we begin to differentiate the paradigm that holds the children out (the cognitively based design strategy-- they do not understand and/or a physical one- they are unable to use the closure). Results (proportion of children opening within the first or second five minute periods of test and time to opening during the same) from each of these, will be compared to results from the third treatment, a standard, commercially available push and turn system. |
Cognitively based design strategy
Participants (42-54 months of age) will be assigned to try to open one of three treatments.
One cohort will receive a 38/400 bottle equipped with the design feature that was introduced as part of the physical intervention (above); however, this treatment is sized such that children should be able to engage it (if they understand how).
In having these three treatments, we began to evaluate the paradigm which enables the design to work.
(Do they fail to understand how?- Cognitive treatment fail- and or Can they not effectively manipulate the closure?
--- Physical failure).
|
Two novel designs for child resistant closures are tested. One is sized based on the anthropometric properties of adults and children's hands such that it should disallow children from engaging the system and enable adults (the physically based design strategy). The other replicates the first design, but is sized such that either of the two populations should be able to engage the closure. In testing this way, we begin to differentiate the paradigm that holds the children out (the cognitively based design strategy-- they do not understand and/or a physical one- they are unable to use the closure). Results (proportion of children opening within the first or second five minute periods of test and time to opening during the same) from each of these, will be compared to results from the third treatment, a standard, commercially available push and turn system. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of successful openings within a given treatment
Time Frame: First five minutes OR Second five minutes
|
Openings are recorded in binary fashion (child was successful yes/no)
|
First five minutes OR Second five minutes
|
Time to successful opening
Time Frame: First five minutes OR Second five minutes
|
The time it took for children to successfully open the packaging
|
First five minutes OR Second five minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MSU17-1447
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Unintentional Injury
-
Tianjin SinoBiotech Ltd.Peking University Cancer Hospital & InstituteCompletedCancer | Tumor | Underdose (Unintentional)China
-
Michigan State UniversityCompletedUnintentional Ingestion of Drugs Contained Within Prescription Vials and Blisters.United States
-
Massachusetts General HospitalCompletedInjuries | Injury;Sports | Injury, Knee | Injury Arm | Injury Wrist | Injury, Ankle | Injury Foot | Injury, Hand | Injury Finger | Injury LegUnited States
-
University of PittsburghUnited States Department of DefenseCompletedExtremity Injury | Muscle Injury | Soft Tissue Injury | Traumatic Injury | Tendon InjuryUnited States
-
University of PittsburghUnited States Naval Medical Center, San Diego; United States Naval Medical...WithdrawnExtremity Injury | Muscle Injury | Soft Tissue Injury | Traumatic Injury | Tendon InjuryUnited States
-
Medical University InnsbruckCompletedSport Injury | Traumatic Injury | Peroneal Nerve Injury
-
Northern Vermont UniversityCompletedInjury;Sports | Injury, Knee | Injury, Ankle | Injury LegUnited States
-
Sunnybrook Health Sciences CentreActive, not recruitingMusculoskeletal Injury | Traumatic InjuryCanada
-
University of California, San FranciscoNational Center for Advancing Translational Sciences (NCATS)Not yet recruitingTrauma Injury | Survivorship | Injury TraumaticUnited States
-
Oregon Health and Science UniversityCompletedInjury of Duodenum | Pancreatic InjuryUnited States
Clinical Trials on Novel approaches for the design of child resistant closures
-
University Hospital Inselspital, BerneAmniSure International LLCCompletedPreterm Birth | Preterm LabourSwitzerland
-
University of California, San DiegoCompleted
-
Cairo UniversityUnknown
-
University of DerbyRecruitingOld Age; Debility | Stability | Balance; DistortedUnited Kingdom
-
University Hospital, AngersUnknown
-
ImagiRation, LLCCompletedAutistic Disorder | Autism | ASDUnited States
-
Nantes University HospitalCompletedBacterial InfectionFrance
-
Meyer Children's Hospital IRCCSActive, not recruitingFeeding and Eating Disorders of ChildhoodItaly
-
Centre Hospitalier Universitaire, AmiensRecruitingSleep | Newborn | Chemical Pollutants ExposureFrance
-
Centre Hospitalier Universitaire DijonRecruiting